FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/068546 [Registered on: 06/06/2024] Trial Registered Prospectively
Last Modified On: 31/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Siddha 
Study Design  Single Arm Study 
Public Title of Study   A Clinical trail on Parangipattai chooranam in the management of Azhal keel vaayu (Osteoarthritis of Knee) among patients attending OPD and IPD of Government Siddha Medical College and Hospital, Palayamkottai  
Scientific Title of Study   A Prospective,open labelled, single arm,non randomized, single centric,phase II,clinical trial to determine the effectiveness of parangipattai chooranam in the management of azhal keel vaayu (osteoarthritis of knee) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  S KAVIYA  
Designation  PG scholar 
Affiliation  Government Siddha Medical College and Hospital palayamkottai 
Address  Op number 10, PG department of Pothu Maruthuvam, Government Siddha Medical College and Hospital, Tiruvananthapuram main road, Palayamkottai, Tirunelveli
Government Siddha Medical College and Hospital, Tiruvananthapuram main road, Palayamkottai 627002
Tirunelveli
TAMIL NADU
627002
India 
Phone  9443722681  
Fax    
Email  kaviya17081998@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr P Sathish kumar 
Designation  Lecturer  
Affiliation  Government Siddha Medical College and Hospital  
Address  Op number 10, PG Department of Pothu Maruthuvam, Government Siddha Medical College and Hospital,Tiruvananthapuram main road,Palayamkottai Tirunelveli.
Government Siddha Medical College and Hospital Tiruvananthapuram main road Palayamkottai
Tirunelveli
TAMIL NADU
627002
India 
Phone  9944337757  
Fax    
Email  drpsk_md@yahoo.in  
 
Details of Contact Person
Public Query
 
Name  Prof Dr T Komalavalli Alias Mehala 
Designation  Head of the department  
Affiliation  Government Siddha Medical College and Hospital  
Address  Op number 10,PG department of Pothu Maruthuvam,Government Siddha Medical College and Hospital Tiruvananthapuram main road Palayamkottai Tirunelveli
Government Siddha Medical College and Hospital,Tiruvananthapuram main road,Palayamkottai
Tirunelveli
TAMIL NADU
627002
India 
Phone  9788122691  
Fax    
Email  komalaarumugam1@gmail.com  
 
Source of Monetary or Material Support  
OPD AND IPD FACILITIES AND CENTRAL LIBRARY OF GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL,TIRUVANANTHAPURAM MAIN ROAD, PALAYAMKOTTAI, TIRUNELVELI-627002,TAMILNADU, INDIA  
 
Primary Sponsor  
Name  Government Siddha Medical College and Hospital 
Address  PG department of Pothu Maruthuvam,Government Siddha Medical College and Hospital,Tiruvananthapuram main road,Palayamkottai Tirunelveli 627002,Tamilnadu, India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Kaviya S  Government Siddha Medical College and Hospital   PG department of Pothu Maruthuvam Government Siddha Medical College and Hospital Tiruvananthapuram main road Palayamkottai
Tirunelveli
TAMIL NADU 
9443722681

kaviya17081998@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICAL COMMITTEE , GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL, PALAYAMKOTTAI   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M170||Bilateral primary osteoarthritis of knee,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  NIL  NIL 
Intervention  PARANGIPATTAI CHOORANAM   DOSAGE:1 to 3 gms,twice a day orally for 48 days with milk 
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1. Patients presenting with Joint pain
2.Morning stiffness for less than 30 minutes
3.Crepitus on active movements
4.Joint line tenderness
5.Difficulty in Range of motion
6.Patient presenting with or without swelling 
 
ExclusionCriteria 
Details  1. Patients with history of Trauma and post- trauma
2.Ligament tear
3.Patient undergone knee replacement surgery
4.Metabolic joint disease
5.Infectious joint disease(tuberculosis,polyarthritis)
6.Inflammatory arthritis(Rheumatoid arthritis)
7.Septic arthritis
8.Osteomyelitis
9.Chronic liver and renal diseases.
10.Malignancy
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
The outcome will be aimed at reducing the symptoms of Azhal keel vaayu and to determine the effectiveness of parangipattai chooranam   48 days 
 
Secondary Outcome  
Outcome  TimePoints 
1.To collect various aspects of Azhal keel vaayu in Siddha literatures.
2.To evaluate physico chemical,phyto chemical and bio chemical characters of parangipattai chooranam.
3. To evaluate safety profile for assessing acute and sub-acute toxicity of trial drug parangipattai chooranam.
4.To evaluate pharmacological analysis of parangipattaichooranam.
5.Study about the prevalence of Azhal keel vaayu in relation between diet and life style.
6.To evaluate siddha parameters (including Envagai thervu) changes and dhegi in Azhal keel vaayu during the study period.
7. To evaluate modern parametric changes in Azhal keel vaayu.
8.To document the Bio statistical analysis.
9. To assess the Quality of life of azhal keel vaayu patients. 
6 months 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   25/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is A PROSPECTIVE OPEN LABELLED, SINGLE ARM, NON- RANDOMIZED, SINGLE CENTRIC, PHASE II CLINICAL TRIAL TO DETERMINE THE EFFECTIVENESS OF PARANGIPATTAI CHOORANAM IN THE MANAGEMENT OF AZHAL KEEL VAAYU (OSTEOARTHRITIS OF KNEE). The trial drug PARANGIPATTAI CHOORANAM  is freshly prepared and will be administered at the dosage of 1 to 3 gms ( Twice a day orally) with milk (pasum paal) as adjuvant for 48 days for 40 osteoarthritis of knee patients ( 20 OP & 20 IP patients). The primary outcome will be determining the effectiveness of PARANGIPATTAI CHOORANAM (INTERNAL) in the management of AZHAL KEEL VAAYU (OSTEOARTHRITIS OF KNEE). The secondary outcome will be to collect various Siddha literatures and modern journals for literature review on AZHAL KEEL VAAYU, to study other cofactors related to disease like age, sex, dietary habits, family history, and socioeconomic status, to perform physicochemical, phytochemical, bio chemical analysis of PARANGIPATTAI CHOORANAM, to evaluate safety profile for acute and sub-acute toxicity of -PARANGIPATTAI CHOORANAM, to evaluate pharmacological activities of PARANGIPATTAI CHOORANAM, to study about the prevalence of AZHAL KEEL VAAYU in relation with diet and lifestyle, to evaluate Siddha parameters (including Envagai thervu, Neerkuri-Neikuri) in AZHAL KEEL VAAYU during trial period, to evaluate DHEGI of AZHAL KEEL VAAYU patients, to evaluate modern parametric changes in AZHAL KEEL VAAYU, to assess the quality of life (QOL) of AZHAL KEEL VAAYU patients and to document Bio statistical analysis

 
Close